GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 182 filers reported holding GW PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is 1.29 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $731,000 | +7.3% | 6,335 | -9.5% | 0.08% | -32.5% |
| Q3 2020 | $681,000 | +55.5% | 6,998 | +67.0% | 0.12% | +172.1% |
| Q4 2019 | $438,000 | -0.7% | 4,191 | +9.2% | 0.04% | +26.5% |
| Q3 2019 | $441,000 | +32.8% | 3,838 | +99.3% | 0.03% | +78.9% |
| Q2 2019 | $332,000 | -55.0% | 1,926 | -74.6% | 0.02% | -52.5% |
| Q4 2018 | $738,000 | -3.0% | 7,574 | +71.9% | 0.04% | -14.9% |
| Q3 2018 | $761,000 | +265.9% | 4,405 | +194.8% | 0.05% | +422.2% |
| Q2 2018 | $208,000 | -90.1% | 1,494 | -90.6% | 0.01% | -91.9% |
| Q4 2017 | $2,098,000 | +14.5% | 15,893 | -12.0% | 0.11% | +22.0% |
| Q3 2017 | $1,832,000 | – | 18,052 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 3,455,054 | $456,102,000 | 8.18% |
| Consonance Capital Management LP | 675,492 | $89,172,000 | 8.05% |
| Prisma Capital Partners LP | 33,000 | $4,356,000 | 4.11% |
| Broadfin Capital, LLC | 122,930 | $16,228,000 | 2.65% |
| Rock Springs Capital Management LP | 354,000 | $46,732,000 | 2.12% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 339,180 | $44,775,000 | 1.76% |
| GREAT POINT PARTNERS LLC | 75,000 | $9,901,000 | 1.69% |
| Atika Capital Management LLC | 31,000 | $4,092,000 | 1.58% |
| Sivik Global Healthcare LLC | 30,000 | $3,960,000 | 1.47% |
| Sio Capital Management, LLC | 19,000 | $2,508,000 | 1.41% |